I'm a researcher whose groundbreaking work could potentially cure a rare genetic disease, but the only way to quickly secure enough funding to complete the trials is to partner with a pharmaceutical company known for exorbitant pricing and questionable ethics. Do I compromise my values for the greater good, or seek a slower, ethically sound path?

Tymon Eliassen

Tymon Eliassen

Partner, expedite cure3 votes (27%)
Seek ethical, slower funding2 votes (18%)
Expose company, then seek2 votes (18%)
Abandon research entirely4 votes (36%)

11 votes total • Created 3/3/2026

Want to vote on this poll? Sign in to asQkme